These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12800604)

  • 81. Synbiotics as Supplemental Therapy for the Alleviation of Chemotherapy-Associated Symptoms in Patients with Solid Tumours.
    Singh NK; Beckett JM; Kalpurath K; Ishaq M; Ahmad T; Eri RD
    Nutrients; 2023 Apr; 15(7):. PubMed ID: 37049599
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer.
    De Clercq K; Xie F; De Wever O; Descamps B; Hoorens A; Vermeulen A; Ceelen W; Vervaet C
    Sci Rep; 2019 Oct; 9(1):14881. PubMed ID: 31619730
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Systemic treatment-induced gastrointestinal toxicity: incidence, clinical presentation and management.
    Boussios S; Pentheroudakis G; Katsanos K; Pavlidis N
    Ann Gastroenterol; 2012; 25(2):106-118. PubMed ID: 24713845
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Phase 2 trial of carboplatin, paclitaxel, and irinotecan in ovarian, fallopian tube, and primary peritoneal cancers.
    Escobar PF; Markman M; Rose P; Zanotti K; Webster K; Belinson J
    Gynecol Oncol; 2004 Jan; 92(1):192-6. PubMed ID: 14751157
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Phase I/II trial of irinotecan, carboplatin, and paclitaxel in advanced or metastatic NSCLC.
    Natale RB; Socinski M; Sandler A; Israel VP; Miller L
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):29-34. PubMed ID: 10981288
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
    du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Toxicity associated with carboplatin/paclitaxel/Irinotecan use in advanced ovarian cancer: preliminary analysis.
    Markman M; Zanotti K; Webster K; Belinson J; Rose P
    Oncology (Williston Park); 2003 May; 17(5 Suppl 5):34-5. PubMed ID: 12800604
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Phase I. Trial of irinotecan plus carboplatin in two dose schedules.
    Jones SF; Burris HA; Hainsworth JD; Yardley DA; Raefsky EA; Miranda FT; Kuzur ME; Willcutt NT; White MB; Greco FA
    Oncology (Williston Park); 2003 May; 17(5 Suppl 5):36-40. PubMed ID: 12800605
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Japanese ovarian trials: focus on irinotecan.
    Sugiyama T; Yakushiji M; Ochiai K; Noda K
    Oncology (Williston Park); 2003 May; 17(5 Suppl 5):29-33. PubMed ID: 12800603
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Carboplatin and Taxol (paclitaxel) in advanced ovarian carcinoma.
    Ozols RF
    Ann Oncol; 1994; 5 Suppl 6():S39-43. PubMed ID: 7865433
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Carboplatin versus cisplatin in ovarian cancer.
    Alberts DS
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):88-90. PubMed ID: 7481869
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer.
    Ozols RF
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):3-7. PubMed ID: 10952119
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

  • 94.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.